Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,336
Closed -$427K 173
2025
Q2
$427K Buy
+4,336
New +$410K 0.05% 74

Other funds holding AMED

Three Seasons Wealth's AMED Position: Q3 2025 in Review

Three Seasons Wealth sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,336 shares — an estimated $427K sold.

Three Seasons Wealth first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $427K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Three Seasons Wealth reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Three Seasons Wealth sold 4,336 Amedisys shares in Q3 2025, an estimated $427K.
  • Three Seasons Wealth first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Three Seasons Wealth's Amedisys position peaked at $427K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Three Seasons Wealth's 13F filing for Q3 2025, filed 17 Oct 2025.